Survival Curve from Scientific Research

Patients with PD-L1 expression level of 1 ≤ CPS < 10. For serplulimab + CF, n = 206, median PFS 5.7 months (95% CI, 5.5–6.3 months). For placebo + CF, n = 104, median PFS 5.3 months (95% CI, 4.2–5.6 months). HR, 0.70; 95% CI, 0.52–0.94; P = 0.017.

DOI